BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3918914)

  • 1. Involvement of the immune system in the pathogenesis of Crohn's disease. Expression of the T9 antigen on peripheral immunocytes correlates with the severity of the disease.
    Raedler A; Fraenkel S; Klose G; Seyfarth K; Thiele HG
    Gastroenterology; 1985 Apr; 88(4):978-83. PubMed ID: 3918914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated numbers of peripheral T cells in inflammatory bowel diseases displaying T9 antigen and Fc alpha receptors.
    Raedler A; Fraenkel S; Klose G; Thiele HG
    Clin Exp Immunol; 1985 Jun; 60(3):518-24. PubMed ID: 2990780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T lymphocyte subsets in inflammatory bowel disease: peripheral blood.
    Selby WS; Jewell DP
    Gut; 1983 Feb; 24(2):99-105. PubMed ID: 6221976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.
    Pallone F; Fais S; Squarcia O; Biancone L; Pozzilli P; Boirivant M
    Gut; 1987 Jun; 28(6):745-53. PubMed ID: 3040543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation and activation phenotypes of lung T lymphocytes differ from those of circulating T lymphocytes.
    Davidson BL; Faust J; Pessano S; Daniele RP; Rovera G
    J Clin Invest; 1985 Jul; 76(1):60-5. PubMed ID: 3926821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell differentiation antigens expressed by peripheral blood lymphocytes in Crohn's disease.
    Pallone F; Squarcia O; Fais S; Boirivant M; Biancone L; Tonietti G
    Boll Ist Sieroter Milan; 1985; 64(5):394-9. PubMed ID: 3937546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral and intestinal lymphocyte activation after in vitro exposure to cow's milk antigens in normal subjects and in patients with Crohn's disease.
    Biancone L; Paganelli R; Fais S; Squarcia O; D'Offizi G; Pallone F
    Clin Immunol Immunopathol; 1987 Dec; 45(3):491-8. PubMed ID: 3677490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Circulating lymphocyte subpopulations in patients with Crohn's disease].
    Sauer D; Sauer H; Fiebig H
    Gastroenterol J; 1991; 51(1):27-32. PubMed ID: 1910492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selected cellular immunity parameters in patients with Lesniowski-Crohn disease].
    Słotwiński R; Szczygieł B; Lech G; Kolewska D; Wasik M
    Pol Merkur Lekarski; 1997 Nov; 3(17):224-7. PubMed ID: 9523477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte subsets and activation antigens in a reference population: a flow cytometric study using single and double antibody staining.
    Schuerch C; Fleetwood M; Glidewell O
    Immunol Invest; 1987 Jun; 16(4):345-60. PubMed ID: 2828230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation.
    Chaux P; Moutet M; Faivre J; Martin F; Martin M
    Lab Invest; 1996 May; 74(5):975-83. PubMed ID: 8642792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CD8+ Leu-7+ subset of T cells in Crohn's disease: distinction between cytotoxic and covert suppressor functions.
    Deem RL; Targan SR; Niederlehner A; Shanahan F
    Clin Exp Immunol; 1990 Jun; 80(3):387-94. PubMed ID: 1695560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulatory function of lamina propria T cells in Crohn's disease.
    James SP; Fiocchi C; Graeff AS; Strober W
    Gastroenterology; 1985 May; 88(5 Pt 1):1143-50. PubMed ID: 2858428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for contrasuppression in patients with Crohn's disease.
    Raedler A; Schreiber S; de Weerth A; Brinkmann B; Sandgren K; Thiele HG; Greten H
    Adv Exp Med Biol; 1988; 237():655-63. PubMed ID: 2978206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological studies in Crohn's disease. I. Association with HLA systems in the Japanese.
    Fujita K; Naito S; Okabe N; Yao T
    J Clin Lab Immunol; 1984 Jun; 14(2):99-102. PubMed ID: 6611420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathology of Crohn's disease.
    Brandtzaeg P
    Ann Gastroenterol Hepatol (Paris); 1985; 21(4):202-20. PubMed ID: 3935037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte activation in vivo in the intestinal mucosa of patients with Crohn's disease.
    Konttinen YT; Bergroth V; Nordström D; Segerberg-Konttinen M; Seppälä K; Salaspuro M
    J Clin Lab Immunol; 1987 Feb; 22(2):59-63. PubMed ID: 3298655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major histocompatibility class II expression on the small intestinal nervous system in Crohn's disease.
    Geboes K; Rutgeerts P; Ectors N; Mebis J; Penninckx F; Vantrappen G; Desmet VJ
    Gastroenterology; 1992 Aug; 103(2):439-47. PubMed ID: 1378803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.